Patient-Centric Biosensors Market Thrives: $14.3 Billion Segment by 2030 as Demand for Personalized Diagnostics Rises
Patient-centric biosensors are redefining diagnostics, prioritizing comfort, convenience, and personalized insights. These devices, designed to empower patients with ownership over their health data, are aligning with modern demands for autonomy and proactive care. The patient-centric biosensor segment, valued at $6.8 billion in 2023, is projected to reach $14.3 billion by 2030, growing at a...
0 التعليقات 0 المشاركات 601 مشاهدة 0 معاينة